BR112012023485A2 - marcadores moleculares para infecções do trato urinário. - Google Patents

marcadores moleculares para infecções do trato urinário.

Info

Publication number
BR112012023485A2
BR112012023485A2 BR112012023485A BR112012023485A BR112012023485A2 BR 112012023485 A2 BR112012023485 A2 BR 112012023485A2 BR 112012023485 A BR112012023485 A BR 112012023485A BR 112012023485 A BR112012023485 A BR 112012023485A BR 112012023485 A2 BR112012023485 A2 BR 112012023485A2
Authority
BR
Brazil
Prior art keywords
urinary tract
tract infections
molecular markers
procalcitonin
infections
Prior art date
Application number
BR112012023485A
Other languages
English (en)
Other versions
BR112012023485B1 (pt
Inventor
Fancesco Giunta
Francesco Forfori
Giada Seri
Original Assignee
Brahms Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brahms Gmbh filed Critical Brahms Gmbh
Publication of BR112012023485A2 publication Critical patent/BR112012023485A2/pt
Publication of BR112012023485B1 publication Critical patent/BR112012023485B1/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/585—Calcitonins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/348—Urinary tract infections

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • External Artificial Organs (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

marcadores moleculares para infecções do trato urinário. a invenção refere-se a um método in vitro para determinar níveis de procalcitonina em plasma e urina como um marcador diagnóstico para identificar pacientes com infecções do trato urinário, método in bvitro para realizar referida determinação, um kit para diagnose de pacientes com infecções do trato urinário, e a utilidade da procalcitonina na diagnose de infecções do trato urinário.
BR112012023485-4A 2010-03-18 2011-03-15 Marcadores moleculares para infecções do trato urinário BR112012023485B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2010A000121 2010-03-18
IT000121A ITRM20100121A1 (it) 2010-03-18 2010-03-18 Marcatori molecolari per infezioni delle vie urinarie.
PCT/IB2011/051073 WO2011114287A2 (en) 2010-03-18 2011-03-15 Molecular markers for urinary tract infections

Publications (2)

Publication Number Publication Date
BR112012023485A2 true BR112012023485A2 (pt) 2016-05-24
BR112012023485B1 BR112012023485B1 (pt) 2020-03-17

Family

ID=42630320

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012023485-4A BR112012023485B1 (pt) 2010-03-18 2011-03-15 Marcadores moleculares para infecções do trato urinário

Country Status (11)

Country Link
US (2) US8748195B2 (pt)
EP (1) EP2548031B1 (pt)
JP (1) JP5681219B2 (pt)
CN (1) CN102939542B (pt)
BR (1) BR112012023485B1 (pt)
ES (1) ES2484720T3 (pt)
HK (1) HK1180392A1 (pt)
IT (1) ITRM20100121A1 (pt)
RU (1) RU2611371C2 (pt)
WO (1) WO2011114287A2 (pt)
ZA (1) ZA201206633B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2592228C2 (ru) * 2014-04-10 2016-07-20 Владимир Игоревич Павлов Способ (варианты) и набор для диагностики инфекции мочевыводящих путей, способ лечения и определения предрасположенности к инфекции мочевыводящих путей
RU2679629C1 (ru) * 2018-07-05 2019-02-12 Антонина Ни Способ диагностики воспалительного процесса органов мочевыделительной системы у детей раннего возраста
RU2724186C1 (ru) * 2020-01-23 2020-06-22 Наталья Борисовна Гусева Способ лечения детей раннего возраста с рецидивирующей инфекцией мочевой системы
RU2766811C1 (ru) * 2021-06-22 2022-03-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ применения маркеров бактериального воспаления для диагностики инфекции мочевыводящих путей у детей первых трех лет жизни

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
DE602006021768D1 (de) * 2005-09-28 2011-06-16 Dickinson & Co Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands
DE102007009751A1 (de) * 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
ES2377112T3 (es) * 2007-08-03 2012-03-22 B.R.A.H.M.S Gmbh Método para el diagnóstico de una infección bacteriana
EP2320237B1 (en) * 2009-10-13 2016-08-03 B.R.A.H.M.S GmbH Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
JP5798133B2 (ja) * 2010-03-08 2015-10-21 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 不特定の愁訴を示す患者における細菌感染及び抗生物質治療の指標を診断するために用いられるプロカルシトニン
BR112012028331B1 (pt) * 2010-05-04 2020-04-28 Ethicon Endo Surgery Llc sutura de autorretenção

Also Published As

Publication number Publication date
RU2611371C2 (ru) 2017-02-21
JP5681219B2 (ja) 2015-03-04
US20140242725A1 (en) 2014-08-28
CN102939542A (zh) 2013-02-20
HK1180392A1 (en) 2013-10-18
ES2484720T3 (es) 2014-08-12
WO2011114287A3 (en) 2011-12-15
EP2548031B1 (en) 2014-05-21
RU2012144233A (ru) 2014-04-27
WO2011114287A2 (en) 2011-09-22
US20130084650A1 (en) 2013-04-04
ZA201206633B (en) 2015-04-29
ITRM20100121A1 (it) 2011-09-19
JP2013522618A (ja) 2013-06-13
BR112012023485B1 (pt) 2020-03-17
EP2548031A2 (en) 2013-01-23
CN102939542B (zh) 2015-07-08
US8748195B2 (en) 2014-06-10

Similar Documents

Publication Publication Date Title
BR112013004673A2 (pt) biomarcadores e métodos de tratamento.
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
ATE533061T1 (de) Verfahren zur diagnose bakterieller infektionen
BR112013012460A2 (pt) "kit de diagnóstico para biomarcadores de benefício de saúde vaginal e método para a detecção de biomarcadoeres de benefício de saúde vaginal"
BR112013010952A2 (pt) sistemas de rmn e métodos para a detecção rápida de analisados
WO2010099342A3 (en) Methods of detecting lung cancer
BRPI0720371B8 (pt) métodos para diagnóstico ou monitoramento da progressão de câncer de próstata em um indivíduo e uso in vitro de pelo menos um homeodomínio contendo o fator de transcrição como um biomarcador para câncer de próstata
BR112014031365A2 (pt) métodos de detectar doenças ou condições
BR112012029281A2 (pt) anticorpo trop-2 anti-humano tendo atividade anti-tumor in vivo
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
ES2570632T3 (es) Procedimiento de determinación del inhibidor de elastasa de leucocito in vitro del cáncer colorrectal
BR112014031957A2 (pt) bag3 como soro bioquímico e marcador de tecido
BRPI0918386A2 (pt) métodos de avaliação de um paciente para incontinência urinária de esforço, sistema de avaliação de um paciente para incontinência urinária de esforço e dispositivo para avaliação de um paciente para incontinência urinária de esforço
WO2008111464A1 (ja) スプライシング異常を指標とする抗ガン剤の作用検定方法
AR088244A1 (es) oxMIF COMO MARCADOR DE DIAGNOSTICO
BR112012023485A2 (pt) marcadores moleculares para infecções do trato urinário.
BRPI0913477A2 (pt) "método para desenvolvimento de marcador diagnóstico"
BR112014009223A8 (pt) método para o diagnóstico da doença de niemann-pick
BR112012013328A8 (pt) Métodos para detectar mycoplasma pneumoniae ou mycoplasma genitalium
WO2013009146A3 (ko) 당뇨망막병증 진단용 마커 및 이의 용도
BR112013031431A2 (pt) método para o diagnóstico da doença de gaucher
CL2007003659A1 (es) Kit de deteccion de microorganismos patogenos mediante pruebas de aliento.
MX2013002652A (es) Metodos y equipos para la deteccion de una infeccion en sujetos con bajos niveles de anticuerpos especificos.
DE602007011542D1 (de) Schätzsystem für einen Indikator für Körperzusammensetzungen

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/03/2011, OBSERVADAS AS CONDICOES LEGAIS.